TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 6 | 0 | 6 | 2 | -8 | -4 | 4 | -0 | 
| S | %wins | 50 | 50 | 83 | 67 | 50 | 50 | 58 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/25 16:07  | 9/12/25  | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shih Alvin | FL | D | P | 158 | 7.89 | 0 | 20 | New | 20 | D | |||||||||||||||
9/2/16 21:26  | 9/1/16  | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shih Alvin | CA | O | EVP of R | S | -142 | 16.24 | 7 | -9 | -5 | 158 | D | 17 | -42 | 10 | -8 | -10 | -6 | -4 | 1 | 1 | 32 | 43 | 21 | 31 | |
6/2/16 21:04  | 6/1/16  | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shih Alvin | CA | O | EVP of R | S | -155 | 17.75 | 8 | -9 | -5 | 167 | D | 23 | -44 | -20 | 16 | 18 | 16 | 6 | 3 | -3 | 0 | -2 | -11 | 18 | |
3/1/16 18:35  | 3/1/16  | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shih Alvin | CA | O | EVP of R | S | -126 | 14.35 | 8 | -9 | -5 | 176 | D | -26 | 0 | -48 | -36 | -16 | 0 | 0 | -5 | 3 | 6 | -11 | 18 | 10 | 45 | 
12/10/15 20:50  | 12/9/15  | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shih Alvin | CA | O | EVP of R | S | -182 | 20.83 | 9 | -9 | -5 | 185 | D | 154 | 109 | -34 | -26 | 4 | 2 | -8 | -6 | -3 | 3 | -16 | -28 | -16 | 0 | 
10/8/15 21:49  | 10/6/15  | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shih Alvin | CA | O | EVP of R | S | -176 | 20.12 | 20 | -9 | -4 | 193 | D | 194 | 85 | -15 | -37 | -25 | -32 | 0 | -9 | 6 | -4 | -1 | -8 | -22 | 20 | 
6/30/15 17:32  | 6/26/15  | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shih Alvin | CA | O | EVP of R | S | -913 | 32.70 | 20 | -28 | -12 | 202 | D | 535 | 164 | 145 | 31 | 18 | 1 | -7 | -5 | -2 | -2 | -4 | -42 | -43 | -48 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |